Search This Blog

Wednesday, December 28, 2022

Immunogen noted as preferred cancer therapy: Blair

 

Wiliam Blair Issues Note Regarding New Guidelines On A ImmunoGen Drug, The National Comprehensive Cancer Network Just Released New Guideline Which Include Elahere, As A Preferred Regimen

https://www.benzinga.com/general/biotech/22/12/30217302/wiliam-blair-issues-note-regarding-new-guidelines-on-immunogen-the-national-comprehensive-cancer-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.